Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > CEO Q&A session

<< Previous

Bullboard Posts

Next >>

Post by Firepokeron May 04, 2023 6:03pm

126 Views

Post# 35431391

CEO Q&A session

Well where are all the bashers when they can bash the top dog.. ?
Cowards and Bottomfeeders they be.
That was a nice Q&A session... His passion and 100% dedication to making MDMA, Cortexa, and any other future spin-offs, successful is motivating.
Nick, the Golden Goose.
Stay Focused.
If you would like to read the Q&A session...go to MDMA CEO.CA board...it will be saved in community link, as the last one was no doubt.

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement